Literature DB >> 19668800

Percutaneous ethanol ablation of hepatocellular carcinoma: periprocedural onset alcohol toxicity and pancreatitis following conventional percutaneous ethanol ablation treatment.

Kirsteen Rennie Burton1, Helena O'Dwyer, Charles Scudamore.   

Abstract

A novel case of acute pancreatitis in a patient treated with percutaneous ethanol injection (PEI) ablation for hepatocellular carcinoma is described. The most commonly reported adverse effects of PEI are hepatic or peritoneal hemorrhage, hepatic insufficiency or infarction. There are no previous reports of fatal acute pancreatitis as a result of conventional PEI.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19668800      PMCID： PMC2732177          DOI： 10.1155/2009/480693

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


  14 in total

1.  Two cases of acute necrotizing pancreatitis complicating after transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  Hideyuki Komekado; Hiroyuki Kokuryu; Toru Kimura; Takanori Maruo; Ryuichi Kita; Yukio Osaki; Masayuki Shintaku; Tateo Sawabu; Hiroshi Seno
Journal:  J Gastroenterol       Date:  2005-01       Impact factor: 7.527

Review 2.  The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.

Authors:  Christopher J Gannon; Steven A Curley
Journal:  Semin Radiat Oncol       Date:  2005-10       Impact factor: 5.934

Review 3.  Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.

Authors:  M C Jansen; R van Hillegersberg; R A F M Chamuleau; O M van Delden; D J Gouma; T M van Gulik
Journal:  Eur J Surg Oncol       Date:  2005-05       Impact factor: 4.424

4.  Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.

Authors:  A Giorgio; L Tarantino; G de Stefano; A Perrotta; V Aloisio; L del Viscovo; A Alaia; G Lettieri
Journal:  Eur J Ultrasound       Date:  2000-12

5.  Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates.

Authors:  M Di Stasi; L Buscarini; T Livraghi; A Giorgio; A Salmi; I De Sio; F Brunello; L Solmi; E Caturelli; F Magnolfi; M Caremani; C Filice
Journal:  Scand J Gastroenterol       Date:  1997-11       Impact factor: 2.423

6.  Hyperamylasemia after hepatic resection.

Authors:  T Tsuzuki; S Shimizu; S Takahashi; H Iio
Journal:  Am J Gastroenterol       Date:  1993-05       Impact factor: 10.864

7.  Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia.

Authors:  T Livraghi; S Lazzaroni; S Pellicanò; S Ravasi; G Torzilli; C Vettori
Journal:  AJR Am J Roentgenol       Date:  1993-11       Impact factor: 3.959

8.  Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma.

Authors:  T Livraghi; V Benedini; S Lazzaroni; F Meloni; G Torzilli; C Vettori
Journal:  Cancer       Date:  1998-07-01       Impact factor: 6.860

9.  Anesthetic techniques and complications in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection.

Authors:  S Nimmaanrat; C Prechawai; W Tanomkiat
Journal:  Minerva Anestesiol       Date:  2007-06       Impact factor: 3.051

10.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.